Antiparkinson Drugs Flashcards Preview

Neuro 3 > Antiparkinson Drugs > Flashcards

Flashcards in Antiparkinson Drugs Deck (28)
Loading flashcards...
1
Q

PD causes, risk facotrs, cardinal symptoms

A

95% idio patic…5% familia

Positive - age, heredity, sex, toxic

Negative - coffee, tobacco, NSAIDs

Resting tremor - pill rolling
Muscular cogwheel rigidity
Bradykineia - slowness and restricteed movement

2
Q

Pathology, why survival time, and reflex vs. coluntary

A

Loss of dopamanergic in SN
Hallmark lewy bodies
>80% loss before symtoms

Mitchondrial dysfunction, ROS, excititoxic glutamate exposure

3-5 yrs untreated
5-10 yrs tx

Reflexes intact but voluntayr slower

3
Q

PD subtypes

A

PD - less common…tremor main complaint…younger patients…slower

PDD - postural imabalance and gait…>70 y/o at diagnosis…akinesia, rigidity…rapid decline

4
Q

Parkinsonism

A

Drug induced PD symptoms (due to DA antagonists like antipsychotics)

5
Q

MPTP

A

MPTP protoxin taken up by DAergic neurons via transporter…converted to MPP+ by MAOB in astrocytes…MPP+ interferes with mitochondria…free radical uidup and death

6
Q

Levodopa/L-Dopa mech and rationale

A

DA does not cross BBB

Prodrug has no action…crosses the BBB (unlike DA)…decarboxylated ti DA in ingrostriatal neurons…seuqestered in vesicles avaiable for release into DA deprived striatum

7
Q

Dopamine creation

A

Tyroosine to L-dopa to dopamine

8
Q

L-DOPA therapeutics

A

Gold standard
Efficacy decreases as disease progresses
NEver given alone

9
Q

L-DOPA kinetics

A

AA in diet compete iwht L-DOPA for transport

Metabolized to HVA and DOPAC

1-3% into CNS

10
Q

Clinical use and side effects of LDOPA

A

On target effects weaken and side effects strengthen as dz progresses…best early

Peripheral (because of L-DOpa to DOpa conversion)…GI distrubrances because of DOPA decarboylase in gut…tachycardia and hypotension

Central - wearing off (associated with dosing schedule), on/off(NOT associated with dosing scheudle), abnormal involuntary movements, psychotomimetic

11
Q

L-Dopa interactions and contraindiciations

A

Vit B6 (enhances metabolism) or within 2 weeks of MAOA (hypertensive crisis)

Psychosis, glaucoma, cardiac dz, peptic ulcers, melanoma

12
Q

Carbidopa

A

L-DOPA given with
DOes not cross BBB
Reduces Nausea and CV effects
IMproves delivery to CNS

DOpa decarbozylase inhibitors

13
Q

Rationale of COMT inhibitors

A

Inhibiting peripheral DOPA decarbozylase upregulates COMT…converts L-DOPA to 3OMD…competes with L-DOPA for BBB transport to CNS

14
Q

Entacapone, stalevo with side effects

A

Preferred…does not cross BBB
Entacopone + carbidopa+L-DOPA

Organge colored urine is main one

15
Q

Dopamine agnosits advantage and disadvantages

A
Do not require nigrostriatal neurons or metabolic conversion
Longer duration
Selective for D2 subtype
Do not conpete for trnapsort 
Can be monotherapeutic 

Not under neuronal control
Off target

16
Q

Dopamine agnost side effect

A

N/V, sleepiness, insomnia, AIMs

17
Q

Bromocriptine

A
Absorbed in gut 
Peak in 1-2 horus 
Excreted in bile and feces 
Ergot based
Newer, non-ergot DA agnoists are preferred
18
Q

Pramipexole

A

Antioxidant free radical svaneger
May be neuroprotective
Excreted by kindey
Renal insufficiency could be problem

19
Q

Ropinirole

A

Metabolized by CYP1A2…competing could slow clearance

20
Q

Pramiprexole and ropinirole are both

A

DA2 type agnosits
Slow titration needed
Monotherapy for mild

21
Q

Rotigotine

A

One daily pathc
Binds D3 more strongly
DA2>DA1

22
Q

APomorphine mech, indicaion, pharmacokinetics, side effects

A

Potent non selective DA agonist
Relief of the off state
Delivered subq…lasts 2 hours…quick acting
Nausea

23
Q

DA agonist side effects and contraindications

A

GI (N/V constipation)
CV (hypotension with vasospasm)
Dyskinesia
Mental disturbance

Psychosis, MI, peripheral ascular dz (for ergot)

24
Q

MAOI rationale

A

MAOB inhibition will increase DA avialbility and lower ox strsss

25
Q

Selegiline mech and side effedcts

A

Selective and irreversible MAOB

Modd elevating, N/V, dry mouth

26
Q

Amantadine

A

Rduces dyskinesia late in PD progression
Adjunct iwht sinemet
Worry about renal dz
Similar to L-DOPA side effects

Contra with history of seizure or heart failure

27
Q

Muscarinic antagonist

A

Reducing Ach can balance Ach:DA ration

No effect on brady kinesia but can reduce tremor and rigidity

Start low and tritrate up

28
Q

Trihexyphenidyl

A

Muscarinic antagonist